Accepted for/Published in: Journal of Medical Internet Research
Date Submitted: Aug 3, 2020
Date Accepted: Oct 11, 2020
Date Submitted to PubMed: Nov 16, 2020
COVID-19 Mobile Apps: A Systematic Review of the Literature
ABSTRACT
Background:
A vast amount of mobile apps have been developed during the past few months in an attempt to “flatten the curve” of the increasing number of COVID-19 cases.
Objective:
This systematic review aims to shed light into studies found in the scientific literature, which have used and evaluated mobile apps for the prevention, management, treatment, and/ or follow-up of COVID-19.
Methods:
We searched the bibliographic databases of COVID-19 global literature on coronavirus disease, PubMed and Scopus, to identify papers focusing on mobile apps for COVID-19 that (i) show evidence on their real-life use and (ii) have been developed involving clinical professionals in their design or validation.
Results:
Mobile apps have been implemented for training, information sharing, risk assessment, self-management of symptoms, contact tracing, home-monitoring and decision making, rapidly offering effective and usable tools against the COVID-19 pandemic.
Conclusions:
Mobile apps are considered to be a valuable tool for citizens, health professionals and decision makers in facing critical challenges imposed by the pandemic, such as reducing the burden of hospitals, providing access to credible information, tracking symptoms and the mental health of individuals, and discovering new predictors of COVID-19.
Citation
Request queued. Please wait while the file is being generated. It may take some time.
Copyright
© The authors. All rights reserved. This is a privileged document currently under peer-review/community review (or an accepted/rejected manuscript). Authors have provided JMIR Publications with an exclusive license to publish this preprint on it's website for review and ahead-of-print citation purposes only. While the final peer-reviewed paper may be licensed under a cc-by license on publication, at this stage authors and publisher expressively prohibit redistribution of this draft paper other than for review purposes.